Welcome: Guest | Site Use Options | Register | Login |

NIH 2020 A Reversible Aptamer Based Therapeutic to Treat Stroke

A Reversible Aptamer Based Therapeutic to Treat Stroke

 Project Summary
Program: SBIR Agency: NIH
(NHLBI)
Phase I Year: 2020 Phase II Year: 2021
Phase I Dollars: Phase II Dollars:
Principal Investigator:

   Phase I Abstract   
Occlusive arterial thrombosis leading to stroke and myocardial infarction contribute to ~13 million deaths around the world every year. Over the past two decades, recombinant tissue plasminogen .....

   Phase II Abstract   
Occlusive arterial thrombosis leading to stroke and myocardial infarction contribute to ~13 million deaths around the world every year. Over the past two decades, recombinant tissue plasminogen .....

Recipient Firm

1275 Kinnear Road
Columbus, OH 43212

(919) 423-5043
mail@baskingbiosciences.com
www.baskingbiosciences.com

Principal point of contact
President/CEO:  N/A

SBIR firms in the news



Contact information

Innovation Development Institute, LLC

   45 Beach Bluff Avenue, Suite 300
     Swampscott,  MA 01907-1542

  Tel:  (781) 595-2920

  support@inknowvation.com